Literature DB >> 31778081

Colonic stents for malignant bowel obstruction: current status and future prospects.

Vittorio Maria Ormando1, Rossella Palma1, Alessandro Fugazza1, Alessandro Repici1.   

Abstract

Introduction: Although more than two decades are already passed from the first description of this technique, the debate remains open on the role of self-expanding metal stents (SEMS) placement in the management of malignant bowel obstruction (MBO). According to most recent data, SEMS placement is considered a safe and effective alternative treatment as a bridge to surgery(BTS). In addition, stent placement should be considered as primary option for palliative treatment of obstructing cancer.Areas covered: Current status, indication, technique, oncological outcomes, advantages, and risks of SEMS placement in MBO were reviewed.Expert commentary: The placement of colonic SEMS for palliation and for BTS in patients with MBO has been increasingly reported and it seems to have several advantages over emergency surgery. Substantial concerns of tumor seeding following SEMS placement, especially in case of perforation, have been raised in numerous studies. Actually, no significant differences are reported in oncologic long-term survival between patients undergoing stent placement as a BTS and those undergoing emergency surgery. Considering all the mentioned factors, indication for colorectal stenting should be evaluated only in highly specialized centers, in the context of multidisciplinary approach where risks and benefits of stenting are carefully weighed, especially in the BTS setting.

Entities:  

Keywords:  Colorectal cancer; bowel obstruction; bridge to surgery; colonoscopy; emergency surgery; endoscopy; palliation; self-expandable metal stent

Mesh:

Year:  2019        PMID: 31778081     DOI: 10.1080/17434440.2019.1697229

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  6 in total

1.  Self-expandable metallic stenting as a bridge to elective surgery versus emergency surgery for acute malignant right-sided colorectal obstruction.

Authors:  Bing Li; Shi-Lun Cai; Zhen-Tao Lv; Ping-Hong Zhou; Li-Qing Yao; Qiang Shi; Zhi-Peng Qi; Di Sun; Ayimukedisi Yalikong; En-Pan Xu; Jian-Min Xu; Yun-Shi Zhong
Journal:  BMC Surg       Date:  2020-12-10       Impact factor: 2.102

2.  Safety and feasibility of neoadjuvant chemotherapy as a surgical bridge for acute left-sided malignant colorectal obstruction: a retrospective study.

Authors:  Jiawei Zhang; Jiaxin Deng; Jiancong Hu; Qinghua Zhong; Juan Li; Mingli Su; Wei Liu; Miwei Lv; Tian Xu; Dezheng Lin; Xuefeng Guo
Journal:  BMC Cancer       Date:  2022-07-21       Impact factor: 4.638

3.  Predictors of clinical outcomes of self-expandable metal stent treatment for malignant colorectal obstruction: A Honam Association for the Study of Intestinal Disease (HASID) multicenter study.

Authors:  Bora Han; Ji-Yun Hong; Eun Myung; Hyung-Hoon Oh; Hee-Chan Yang; Sang-Wook Kim; Jun Lee; Seong-Jung Kim; Yeom-Dong Han; Geom-Seok Seo; Gun-Young Hong; Ho-Dong Kim; Hyun-Soo Kim; Young-Eun Joo
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

4.  Self-expanding metal stent insertion by colorectal surgeons using a two-person approach colonoscopy without fluoroscopic monitoring in the management of acute colorectal obstruction: a 14-year experience.

Authors:  Fei-Hu Yan; Yao Zhang; Cheng-Ling Bian; Xiao-Shuang Liu; Bing-Chen Chen; Zhen Wang; Hao Wang; E Ji-Fu; En-da Yu
Journal:  World J Surg Oncol       Date:  2021-07-02       Impact factor: 2.754

5.  Comparison of safety between self-expanding metal stents as a bridge to surgery and emergency surgery based on pathology: a meta-analysis.

Authors:  Yang Hu; Jiajun Fan; Yifan Xv; Yingjie Hu; Yuan Ding; Zhengjie Jiang; Qingsong Tao
Journal:  BMC Surg       Date:  2020-10-27       Impact factor: 2.102

6.  Bridge to surgery using a self-expandable metallic stent for stages II-III obstructive colorectal cancer.

Authors:  Katsuya Ohta; Masakazu Ikenaga; Masami Ueda; Kiyotsugu Iede; Yujiro Tsuda; Shinsuke Nakashima; Takashi Nojiri; Jin Matsuyama; Shunji Endo; Jun Murata; Ichizo Kobayashi; Masahiko Tsujii; Terumasa Yamada
Journal:  BMC Surg       Date:  2020-08-20       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.